Prime Medicine, Inc. SEC filings PRME
Prime Medicine, Inc. has 298 filings in SEC EDGAR's recent list, going back to Dec 20, 2021. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 3, 2026 | — |
| POS AM | Filing | Mar 3, 2026 | — |
| S-3ASR | Automatic shelf registration | Nov 7, 2025 | — |
| 424B5 | Prospectus supplement | Jul 31, 2025 | — |
| 424B5 | Prospectus supplement | Jul 30, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| S-3 | Shelf registration | Dec 13, 2024 | — |
| S-8 | Employee stock plan registration | Mar 1, 2024 | — |
| 424B5 | Prospectus supplement | Feb 16, 2024 | — |
| FWP | Free writing prospectus | Feb 15, 2024 | — |
| 424B5 | Prospectus supplement | Feb 14, 2024 | — |
| S-3 | Shelf registration | Nov 3, 2023 | — |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 424B4 | Prospectus | Oct 21, 2022 | — |
| FWP | Free writing prospectus | Oct 20, 2022 | — |
| S-1MEF | Filing | Oct 19, 2022 | — |
| S-8 | Employee stock plan registration | Oct 19, 2022 | — |
| FWP | Free writing prospectus | Oct 17, 2022 | — |
| S-1/A | Amended registration statement | Oct 17, 2022 | — |
| S-1/A | Amended registration statement | Oct 13, 2022 | — |
| S-1 | Registration statement | Sep 23, 2022 | — |
Showing 21 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- PRME (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1894562
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.